Overview

Gender

male

Investor Type

Investment Partner

Peter joined Novo Ventures (US) Inc. in San Francisco, California in 2009. He is a member of the Board of Directors of Alder Biopharmaceuticals Inc., Asante Solutions Inc., Ceterix Orthopaedics Inc., HTG Molecular Diagnostics Inc., Nevro Corporation, Otonomy Inc. and Thesan Pharmaceuticals Inc. Previously, he was a board member of several EU and US companies.

From 2001-2009, Peter was employed with Novo A/S as a partner in Novo Ventures. Prior to joining Novo A/S he was with McKinsey & Co. as a general consultant and as a specialist within the Scandinavian Corporate Finance and Strategy Group. At McKinsey, Peter focused on strategy development, mergers, acquisitions and alliances in various industries.

Peter is the co-author of 'Growth by Mergers & Acquisitions' published by Børsens Forlag, 2004.

Peter obtained an MSc in 1998 from the Technical University of Denmark and was at the same time awarded a post graduate degree in Mathematical Modelling in Economics by the European Consortium for Mathematics in the Industry.